Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2020 $ 160 $ 546,422 $ (442,514) $ 104,068
Beginning Balance (in shares) at Dec. 31, 2020 159,999,917      
Increase (Decrease) in Stockholders' Equity        
Stock-based compensation expense   1,111   1,111
Exercise of stock options   9   9
Exercise of stock options (in shares) 5,000      
Issuance of common stock, net of issuance costs $ 1 2,791   2,792
Issuance of common stock, net of issuance costs (in shares) 1,219,023      
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes   (69)   (69)
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes (in shares) 49,720      
Net loss     (9,842) (9,842)
Ending Balance at Mar. 31, 2021 $ 161 550,264 (452,356) 98,069
Ending Balance (in shares) at Mar. 31, 2021 161,273,660      
Beginning Balance at Dec. 31, 2021 $ 165 558,566 (494,102) $ 64,629
Beginning Balance (in shares) at Dec. 31, 2021 165,520,007     165,520,007
Increase (Decrease) in Stockholders' Equity        
Stock-based compensation expense   1,155   $ 1,155
Net loss     (16,389) (16,389)
Ending Balance at Mar. 31, 2022 $ 165 $ 559,721 $ (510,491) $ 49,395
Ending Balance (in shares) at Mar. 31, 2022 165,520,007     165,520,007